Heng-Yen Wang

Title: Innovations of Heng-Yen Wang in Nitric Oxide Synthase Inhibition

Introduction

Heng-Yen Wang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit nitric oxide synthases (NOSs). His work has implications for treating various diseases associated with NOS activity.

Latest Patents

Heng-Yen Wang holds 2 patents related to mammalian and bacterial nitric oxide synthase inhibitors. His latest patents disclose compounds that inhibit the biological activity of nitric oxide synthases. These compounds are formulated into pharmaceutical compositions that can be used for treating subjects in need. The disclosed compounds may be utilized in methods for treating individuals who have or are at risk of developing diseases linked to NOS activity.

Career Highlights

Wang is affiliated with Northwestern University, where he continues to advance research in nitric oxide synthase inhibition. His innovative work has garnered attention in the scientific community, contributing to the understanding of NOS-related disorders.

Collaborations

Heng-Yen Wang has collaborated with notable colleagues, including Richard B Silverman and Qing Jing. Their combined expertise enhances the research and development of effective therapeutic solutions.

Conclusion

Heng-Yen Wang's contributions to the field of nitric oxide synthase inhibitors represent a significant advancement in pharmacological research. His innovative patents and collaborations continue to pave the way for new treatment options.